BUDA, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.869
AS - Asia 1.001
EU - Europa 550
SA - Sud America 281
AF - Africa 247
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 11
Totale 3.992
Nazione #
US - Stati Uniti d'America 1.737
SG - Singapore 402
BR - Brasile 195
CN - Cina 156
HK - Hong Kong 118
VN - Vietnam 70
DE - Germania 64
IT - Italia 47
FI - Finlandia 46
PL - Polonia 44
RU - Federazione Russa 37
FR - Francia 30
GB - Regno Unito 25
AR - Argentina 22
SE - Svezia 21
IN - India 18
AT - Austria 16
EC - Ecuador 13
TR - Turchia 13
JP - Giappone 12
LB - Libano 12
ME - Montenegro 12
MU - Mauritius 12
MX - Messico 12
NL - Olanda 12
TT - Trinidad e Tobago 12
UA - Ucraina 12
UZ - Uzbekistan 12
BY - Bielorussia 11
HR - Croazia 11
IQ - Iraq 11
MN - Mongolia 11
PA - Panama 11
RS - Serbia 11
ZA - Sudafrica 11
AE - Emirati Arabi Uniti 10
AO - Angola 10
CH - Svizzera 10
DZ - Algeria 10
KE - Kenya 10
UY - Uruguay 10
BJ - Benin 9
ES - Italia 9
GH - Ghana 9
ID - Indonesia 9
IE - Irlanda 9
LV - Lettonia 9
ML - Mali 9
PE - Perù 9
PT - Portogallo 9
TZ - Tanzania 9
BZ - Belize 8
CA - Canada 8
CZ - Repubblica Ceca 8
LA - Repubblica Popolare Democratica del Laos 8
LU - Lussemburgo 8
MA - Marocco 8
MK - Macedonia 8
NC - Nuova Caledonia 8
PR - Porto Rico 8
SY - Repubblica araba siriana 8
TN - Tunisia 8
TW - Taiwan 8
AF - Afghanistan, Repubblica islamica di 7
AL - Albania 7
AU - Australia 7
AZ - Azerbaigian 7
BB - Barbados 7
CM - Camerun 7
CO - Colombia 7
DO - Repubblica Dominicana 7
EG - Egitto 7
ET - Etiopia 7
HT - Haiti 7
JO - Giordania 7
LC - Santa Lucia 7
PF - Polinesia Francese 7
PH - Filippine 7
SK - Slovacchia (Repubblica Slovacca) 7
UG - Uganda 7
ZW - Zimbabwe 7
AD - Andorra 6
BA - Bosnia-Erzegovina 6
BD - Bangladesh 6
BO - Bolivia 6
CD - Congo 6
CY - Cipro 6
DK - Danimarca 6
EE - Estonia 6
GP - Guadalupe 6
HU - Ungheria 6
IL - Israele 6
KG - Kirghizistan 6
KH - Cambogia 6
LY - Libia 6
NO - Norvegia 6
NP - Nepal 6
PS - Palestinian Territory 6
PY - Paraguay 6
SD - Sudan 6
Totale 3.745
Città #
Fairfield 212
Singapore 204
Ashburn 181
Chandler 164
Houston 134
Woodbridge 118
Hong Kong 113
Cambridge 76
Santa Clara 67
Ann Arbor 65
Seattle 62
Beijing 61
Wilmington 55
Boardman 39
Bytom 34
Ho Chi Minh City 34
Los Angeles 34
Princeton 30
Munich 26
Medford 24
San Diego 22
Des Moines 21
Chicago 20
New York 20
Helsinki 19
Jacksonville 16
Roxbury 15
São Paulo 15
Padova 14
Tashkent 12
Podgorica 11
Ulan Bator 11
Panama City 10
Bamako 9
Brooklyn 9
Buffalo 9
Cotonou 9
Hanoi 9
Vienna 9
Accra 8
Belgrade 8
Dublin 8
Lappeenranta 8
London 8
Luanda 8
Minsk 8
Nairobi 8
Noumea 8
Nuremberg 8
Riga 8
Rio de Janeiro 8
Turku 8
Amman 7
Bridgetown 7
Castries 7
Kampala 7
Luxembourg 7
Montevideo 7
Nanjing 7
Papeete 7
Vientiane 7
Zagreb 7
Andorra la Vella 6
Baghdad 6
Baku 6
Dakar 6
Dar es Salaam 6
Dushanbe 6
Harare 6
Kinshasa 6
Redondo Beach 6
Belize City 5
Bishkek 5
Buenos Aires 5
Cotia 5
Da Nang 5
Dubai 5
Guayaquil 5
Hefei 5
Kigali 5
Les Abymes 5
Libreville 5
Lima 5
Lusaka 5
Managua 5
Phnom Penh 5
Port Louis 5
Port of Spain 5
Pristina 5
Salt Lake City 5
Tallinn 5
Tampa 5
Tunis 5
Warsaw 5
Abidjan 4
Addis Ababa 4
Algiers 4
Athens 4
Banjul 4
Belo Horizonte 4
Totale 2.360
Nome #
Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial 248
Detection of a fluorescent-labeled avidin-nucleic acid nanoassembly by confocal laser endomicroscopy in the microvasculature of chronically inflamed intestinal mucosa 222
MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis 209
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease 186
TAK1 is a key modulator of the profibrogenic phenotype of human ileal myofibroblasts in Crohn’s disease 181
Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region 163
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study 162
Semiautomatic evaluation of crypt architecture and vessel morphology in confocal microendoscopy: Application to ulcerative colitis 150
Biliary Tree Diagnostics: Advances in Endoscopic Imaging andand Tissue Sampling 143
Intestinal Surgery for Crohn's Disease: Predictors of Recovery, Complications and Health Related Quality of Life 133
Expression in ileal mucosa and sub-epitelial myofibroblasts is correlated to a pro-fibrogenetic phenotype in patients with Crohn's disease 131
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 126
Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients 125
Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre 123
Effects of SARS-CoV-2 emergency measures on high-risk lesions detection: a multicentre cross-sectional study 122
Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice 117
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 117
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 113
TAK1 Expression in Ileal Mucosa and Sub-Epithelial Myofibroblasts Is Correlated to a Pro-Fibrogenic Phenotype in Patients with Crohn's Disease 111
Starting a biologic therapy in IBD patients amidst COVID-19: hold, careful monitoring or testing? 104
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results from the SoCOVID-19 Survey 104
The role of wireless capsule endoscopy (WCE) in the detection of occult primary neuroendocrine tumors 101
Increased intestinal permeability in obese mice: new evidences in the pathogenesis of nonalcoholic steatohepatitis. 101
Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction 97
Toward a potential association between eosinophilic esophagitis and Klinefelter syndrome: a case series and review of the literature 97
Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr (EBV) infection 96
Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment? 95
Reply Letter to “Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes” 94
Eosinophilic Esophagitis and Achalasia: Are We Putting All the Pieces Together? 89
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 85
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicenter Case Series 84
Totale 4.029
Categoria #
all - tutte 14.068
article - articoli 13.605
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.673


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021202 0 0 0 0 33 21 12 15 32 33 35 21
2021/2022404 21 50 32 28 42 22 16 41 26 12 41 73
2022/2023291 55 43 8 29 47 35 2 23 29 4 12 4
2023/2024176 4 30 31 17 8 23 13 2 10 4 20 14
2024/2025724 0 48 32 23 94 19 27 61 67 34 134 185
2025/20261.730 159 294 470 495 312 0 0 0 0 0 0 0
Totale 4.029